↓ Skip to main content

Addition of intravenous beta2-agonists to inhaled beta2-agonists for acute asthma

Overview of attention for article published in Cochrane database of systematic reviews, December 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

blogs
3 blogs
twitter
11 tweeters
facebook
1 Facebook page
wikipedia
1 Wikipedia page

Citations

dimensions_citation
44 Dimensions

Readers on

mendeley
100 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Addition of intravenous beta2-agonists to inhaled beta2-agonists for acute asthma
Published in
Cochrane database of systematic reviews, December 2012
DOI 10.1002/14651858.cd010179
Pubmed ID
Authors

Andrew H Travers, Stephen J Milan, Arthur P Jones, Carlos A Camargo Jr, Brian H Rowe

Abstract

Inhaled beta-agonist therapy is central to the management of acute asthma. This review evaluates the benefit of an additional use of intravenous beta(2)-agonist agents.

Twitter Demographics

The data shown below were collected from the profiles of 11 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 100 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 2%
Denmark 1 1%
Unknown 97 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 24 24%
Researcher 15 15%
Unspecified 13 13%
Other 12 12%
Student > Bachelor 11 11%
Other 25 25%
Readers by discipline Count As %
Medicine and Dentistry 58 58%
Unspecified 20 20%
Pharmacology, Toxicology and Pharmaceutical Science 6 6%
Social Sciences 5 5%
Nursing and Health Professions 4 4%
Other 7 7%

Attention Score in Context

This research output has an Altmetric Attention Score of 26. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 May 2018.
All research outputs
#584,244
of 12,989,610 outputs
Outputs from Cochrane database of systematic reviews
#1,929
of 10,437 outputs
Outputs of similar age
#10,243
of 251,606 outputs
Outputs of similar age from Cochrane database of systematic reviews
#113
of 505 outputs
Altmetric has tracked 12,989,610 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,437 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.5. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 251,606 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 505 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.